HAIRY LEUKOPLAKIA-LIKE LESIONS FOLLOWING BONE-MARROW TRANSPLANTATION

被引：31
|
作者：
EPSTEIN, JB [1 ]
SHERLOCK, CH [1 ]
GREENSPAN, JS [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,CTR ORAL AIDS,DEPT STOMATOL,SAN FRANCISCO,CA 94143
来源：
AIDS | 1991年 / 5卷 / 01期
关键词：
HAIRY LEUKOPLAKIA; AIDS; BONE-MARROW TRANSPLANTATION; EPSTEIN-BARR VIRUS;
D O I：
10.1097/00002030-199101000-00016
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Hairy leukoplakia (HL) also occurs in immunosuppressed post-bone-marrow transplantation patients, and in the presence or absence of Epstein-Barr virus. It may not always be diagnostic of HIV positivity. However, HIV status should still be determined in patients with HL.
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [41] BONE-MARROW TRANSPLANTATION - REVIEW AND ESSEN RESULTS
    SCHAEFER, UW
    ZENTRALBLATT FUR CHIRURGIE, 1992, 117 (12): : 701 - 703
  • [42] QUALITY-OF-LIFE FOLLOWING BONE-MARROW TRANSPLANTATION - FINDINGS FROM A MULTICENTER STUDY
    ANDRYKOWSKI, MA
    GREINER, CB
    ALTMAIER, EM
    BURISH, TG
    ANTIN, JH
    GINGRICH, R
    MCGARIGLE, C
    HENSLEEDOWNEY, PJ
    BRITISH JOURNAL OF CANCER, 1995, 71 (06) : 1322 - 1329
  • [43] LONGITUDINAL-STUDY OF ADRENOCORTICAL FUNCTION FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHILDREN
    BOLME, P
    BORGSTROM, B
    CARLSTROM, K
    HORMONE RESEARCH, 1995, 43 (06) : 279 - 285
  • [44] GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION IN RELATION TO BUSULFAN PHARMACOKINETICS
    SLATTERY, JT
    SANDERS, JE
    BUCKNER, CD
    SCHAFFER, RL
    LAMBERT, KW
    LANGER, FP
    ANASETTI, C
    BENSINGER, WI
    FISHER, LD
    APPELBAUM, FR
    HANSEN, JA
    BONE MARROW TRANSPLANTATION, 1995, 16 (01) : 31 - 42
  • [45] SEVERE PULMONARY VASCULAR OCCLUSIVE DISEASE FOLLOWING BONE-MARROW TRANSPLANTATION IN OMENN SYNDROME
    BRUCKMANN, C
    LINDNER, W
    ROOS, R
    PERMANETTER, W
    HAAS, RJ
    HAWORTH, SG
    BELOHRADSKY, BH
    EUROPEAN JOURNAL OF PEDIATRICS, 1991, 150 (04) : 242 - 245
  • [46] Adoptive immunotherapy following allogeneic bone marrow transplantation
    Dazzi, F
    Goldman, JM
    ANNUAL REVIEW OF MEDICINE, 1998, 49 : 329 - 340
  • [47] Rehabilitation following bone marrow transplantation
    Gillis, TA
    Donovan, ES
    CANCER, 2001, 92 (04) : 998 - 1007
  • [48] THE SENSITIVITY OF LEUKEMIC BONE-MARROW TO SIMVASTATIN IS LOST AT REMISSION - A POTENTIAL PURGING AGENT FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    NEWMAN, A
    CLUTTERBUCK, RD
    DELORD, C
    POWLES, RL
    CATOVSKY, D
    MILLAR, JL
    JOURNAL OF INVESTIGATIVE MEDICINE, 1995, 43 (03) : 269 - 274
  • [49] TREATMENT OF BONE-MARROW FAILURE SECONDARY TO NUCLEAR ACCIDENTS - BONE-MARROW TRANSPLANTATION OR HEMATOPOIETIC GROWTH-FACTORS
    DEREVEL, T
    NEDELLEC, G
    AUZANNEAU, G
    MEDECINE ET ARMEES, 1991, 19 (02): : 75 - 79
  • [50] THE EFFECT OF SEQUENCE AND TIME-INTERVAL BETWEEN CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION ON LUNG AND BONE-MARROW DAMAGE FOLLOWING BONE-MARROW TRANSPLANTATION IN MICE
    NIELSEN, OS
    SAFWAT, A
    OVERGAARD, J
    RADIOTHERAPY AND ONCOLOGY, 1993, 29 (01) : 51 - 59
12345